...
ptpi-img

Petros Pharmaceuticals Inc, Common Stock

PTPI

NAQ

$0.369

-$0.13

(-26%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.67M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.17M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.22 L
$2.27 H
$0.369

About Petros Pharmaceuticals Inc, Common Stock

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePTPISectorS&P500
1-Week Return39.28%-3.39%0.2%
1-Month Return90.48%-1.92%2.72%
3-Month Return30.21%-10.54%7.31%
6-Month Return19.05%-4.47%10.44%
1-Year Return-61.24%4.06%27.53%
3-Year Return-98.43%0.94%30.88%
5-Year Return-98.75%36.67%89.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue15.58M9.56M7.81M5.99M5.82M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":61.37,"profit":true},{"date":"2021-12-31","value":50.15,"profit":true},{"date":"2022-12-31","value":38.47,"profit":true},{"date":"2023-12-31","value":37.38,"profit":true}]
Cost of Revenue7.43M4.05M1.60M2.29M1.63M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":54.48,"profit":true},{"date":"2021-12-31","value":21.54,"profit":true},{"date":"2022-12-31","value":30.83,"profit":true},{"date":"2023-12-31","value":21.96,"profit":true}]
Gross Profit8.15M5.51M6.21M3.70M4.19M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.64,"profit":true},{"date":"2021-12-31","value":76.22,"profit":true},{"date":"2022-12-31","value":45.43,"profit":true},{"date":"2023-12-31","value":51.43,"profit":true}]
Gross Margin52.32%57.67%79.52%61.79%71.98%[{"date":"2019-12-31","value":65.79,"profit":true},{"date":"2020-12-31","value":72.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.7,"profit":true},{"date":"2023-12-31","value":90.52,"profit":true}]
Operating Expenses25.02M22.80M24.26M19.55M17.81M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.11,"profit":true},{"date":"2021-12-31","value":96.97,"profit":true},{"date":"2022-12-31","value":78.14,"profit":true},{"date":"2023-12-31","value":71.18,"profit":true}]
Operating Income(16.87M)(17.28M)(18.05M)(15.85M)(13.62M)[{"date":"2019-12-31","value":-1686827500,"profit":false},{"date":"2020-12-31","value":-1728203900,"profit":false},{"date":"2021-12-31","value":-1804801600,"profit":false},{"date":"2022-12-31","value":-1584569000,"profit":false},{"date":"2023-12-31","value":-1361736400,"profit":false}]
Total Non-Operating Income/Expense(30.13M)(7.78M)8.69M(703.65K)5.20M[{"date":"2019-12-31","value":-346.66,"profit":false},{"date":"2020-12-31","value":-89.52,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-8.09,"profit":false},{"date":"2023-12-31","value":59.83,"profit":true}]
Pre-Tax Income(33.16M)(22.01M)(8.99M)(20.04M)(8.16M)[{"date":"2019-12-31","value":-3315716600,"profit":false},{"date":"2020-12-31","value":-2201291800,"profit":false},{"date":"2021-12-31","value":-898667600,"profit":false},{"date":"2022-12-31","value":-2003757300,"profit":false},{"date":"2023-12-31","value":-816318800,"profit":false}]
Income Taxes(645.87K)(1.43M)368.66K7.00M5.65B[{"date":"2019-12-31","value":-0.01,"profit":false},{"date":"2020-12-31","value":-0.03,"profit":false},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":0.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(32.51M)(20.59M)(9.36M)(27.04M)(5.66B)[{"date":"2019-12-31","value":-3251130000,"profit":false},{"date":"2020-12-31","value":-2058592500,"profit":false},{"date":"2021-12-31","value":-935533600,"profit":false},{"date":"2022-12-31","value":-2703757300,"profit":false},{"date":"2023-12-31","value":-565937418800,"profit":false}]
Income From Continuous Operations(32.51M)(20.59M)(8.99M)(20.04M)(12.70M)[{"date":"2019-12-31","value":-3251130000,"profit":false},{"date":"2020-12-31","value":-2058592500,"profit":false},{"date":"2021-12-31","value":-898667600,"profit":false},{"date":"2022-12-31","value":-2003757300,"profit":false},{"date":"2023-12-31","value":-1270269800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(32.51M)(20.59M)(9.36M)(27.04M)(8.16M)[{"date":"2019-12-31","value":-3251130000,"profit":false},{"date":"2020-12-31","value":-2058592500,"profit":false},{"date":"2021-12-31","value":-935533600,"profit":false},{"date":"2022-12-31","value":-2703757300,"profit":false},{"date":"2023-12-31","value":-816318800,"profit":false}]
EPS (Diluted)(17.80)(8.11)(0.91)(2.80)(6.34)[{"date":"2019-12-31","value":-1780.43,"profit":false},{"date":"2020-12-31","value":-811.09,"profit":false},{"date":"2021-12-31","value":-91,"profit":false},{"date":"2022-12-31","value":-280,"profit":false},{"date":"2023-12-31","value":-634.22,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PTPI
Cash Ratio 0.31
Current Ratio 0.85
Quick Ratio 0.74

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PTPI
ROA (LTM) -30.61%
ROE (LTM) -63.77%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PTPI
Debt Ratio Lower is generally better. Negative is bad. 0.85
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.15

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PTPI
Trailing PE NM
Forward PE NM
P/S (TTM) 0.65
P/B 0.86
Price/FCF NM
EV/R 1.50
EV/Ebitda NM

FAQs

What is Petros Pharmaceuticals Inc share price today?

Petros Pharmaceuticals Inc (PTPI) share price today is $0.369

Can Indians buy Petros Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Petros Pharmaceuticals Inc (PTPI) on Vested. To buy Petros Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PTPI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Petros Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Petros Pharmaceuticals Inc (PTPI) via the Vested app. You can start investing in Petros Pharmaceuticals Inc (PTPI) with a minimum investment of $1.

How to invest in Petros Pharmaceuticals Inc shares from India?

You can invest in shares of Petros Pharmaceuticals Inc (PTPI) via Vested in three simple steps:

  • Click on Sign Up or Invest in PTPI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Petros Pharmaceuticals Inc shares
What is Petros Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Petros Pharmaceuticals Inc (PTPI) is $2.27. The 52-week low price of Petros Pharmaceuticals Inc (PTPI) is $0.22.

What is Petros Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Petros Pharmaceuticals Inc (PTPI) is

What is Petros Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Petros Pharmaceuticals Inc (PTPI) is 0.86

What is Petros Pharmaceuticals Inc dividend yield?

The dividend yield of Petros Pharmaceuticals Inc (PTPI) is 0.00%

What is the Market Cap of Petros Pharmaceuticals Inc?

The market capitalization of Petros Pharmaceuticals Inc (PTPI) is $2.67M

What is Petros Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Petros Pharmaceuticals Inc is PTPI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top